Gudrun Fleischhack - Concepedia

Author

Gudrun Fleischhack

Also Known As

Christof Kramm, Cornelis M. van Tilburg, Fleischhack, Gudrun, G Fleischhack, G. Fleischhack, Gudrun Fleischhack, Magnus Sabel

229

Publications

10.8K

Citations

H-Index

Concepts

All Affiliations

University of Bonn Essen University Hospital Universität Hamburg University Medical Center Hamburg-Eppendorf University Hospital Bonn

About

Gudrun Fleischhack is an author at University of Bonn specializing in medicine, oncology, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	34	5.1K
2	Health Sciences	6	6	353
3	Education	1	1	186
4	Social Sciences	1	1	20
5	Emergency Medicine	1	1	15

Gudrun Fleischhack

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
DNA methylation-based classification of central nervous system tumours David Capper, David Jones, Martin Sill, Nature Neuro-oncologyDna Methylation-based ClassificationMedicineEpigenetic ChangeDna Methylation	2018	2.9K
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort Sebastian M. Waszak, Paul A. Northcott, Ivo Buchhalter, The Lancet Oncology	2018	383
Divergent clonal selection dominates medulloblastoma at recurrence A. Sorana Morrissy, Livia Garzia, David Shih, Nature Neuro-oncologySomatic VariantTumor HeterogeneityMedicineGenetics	2016	339
Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study Barbara C. Worst, Cornelis M. van Tilburg, Gnana Prakash Balasubramanian, European Journal of Cancer Health InformaticsCancer LiteracyMedicineCancer ManagementPediatrics	2016	329
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets Cornelis M. van Tilburg, Elke Pfaff, Kristian W. Pajtler, Cancer Discovery	2021	236
Prospective Evaluation of the Thrombotic Risk in Children With Acute Lymphoblastic Leukemia Carrying the MTHFR TT 677 Genotype, the Prothrombin G20210A Variant, and Further Prothrombotic Risk Factors Ulrike Nowak‐Göttl, C. Wermes, Ralf Junker, Blood	1999	195
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004 Ursula Creutzig, Martin Zimmermann, Jean‐Pierre Bourquin, Blood	2013	190
Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology André O. von Bueren, Katja von Hoff, Torsten Pietsch, Neuro-Oncology Surgical OncologyPediatric Brain TumorsMb VariantsConsolidation ChemotherapyCancer Management	2011	186
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters André O. von Bueren, Rolf‐Dieter Kortmann, Katja von Hoff, Journal of Clinical Oncology Pediatric Brain TumorsCancer ManagementSurgerySubgroup StatusNeuro-oncology	2016	184
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort Torsten Pietsch, René Schmidt, Marc Remke, Acta Neuropathologica	2014	145

Page 1